Cardiomyopathy, Dilated: Clinical Trials

46 trials for Cardiomyopathy, Dilated, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 completed, 6 recruiting, 6 unknown, 3 terminated. 46 Phase 2, 14 Phase 1, 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 246Completed 28, Recruiting 6, Unknown 6, Terminated 3, Active not recruiting 1, Suspended 1, Withdrawn 1
Phase 114Completed 6, Recruiting 4, Unknown 2, Terminated 1, Withdrawn 1
Phase 37Completed 4, Unknown 3

Follow Cardiomyopathy, Dilated: new trials by email Literature Review of Cardiomyopathy, Dilated trials Research Report on Cardiomyopathy, Dilated

Trials (filtered) newest first · largest first

All 46 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
AFTX-201 - Dilated Cardiomyopathy (DCM), BAG3 Mutation Associated Dilated Cardiomyopathy
Phase 1 / Phase 2RecruitingAffinia Therapeutics222026-12-012026-11-03
A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)
NVC-001 - Low Dose, NVC-001 - Intermediate Dose, NVC-001 - High Dose - LMNA-Related Dilated Cardiomyopathy
Phase 1 / Phase 2RecruitingNuevocor Pte. Ltd.212026-06-162026-08-07
Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)
HS-005 - Heart Failure, Ischemic Heart Failure
Phase 1 / Phase 2RecruitingHeartseed Inc.142026-01-192026-10-22
the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients
Empagliflozin (EMPA), Standard medical treatment - Heart Failure
Phase 2RecruitingAin Shams University602025-12-012026-07-09
Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
FAP immunosuppressive CAR-DC - Dilated Cardiomyopathy (DCM), Heart Failure
Phase 1 / Phase 2RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine432025-04-222026-07-14
Examining the Effects of Mitochondrial Oxidative Stress in DCM
MitoQ Compound, Placebo - Dilated Cardiomyopathy
Phase 2CompletedImperial College London532022-07-262025-09-18
Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
Ifetroban, Placebo - Duchenne Muscular Dystrophy Cardiomyopathy, Cardiomyopathy, Dilated
Phase 2CompletedCumberland Pharmaceuticals462020-10-192026-03-17
Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation
simvastatin therapy - Dilated Cardiomyopathy
Phase 2RecruitingNational Taiwan University Hospital2302020-08-152024-10-16
Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities
danicamtiv - Primary Familial Dilated Cardiomyopathy
Phase 2TerminatedBristol-Myers Squibb412020-08-042025-05-21
Early Administration of Ivabradine in Children With Heart Failure
Ivabradine 5Mg Tab - Acute Heart Failure, Dilated Cardiomyopathy
Phase 2UnknownBambino Gesù Hospital and Research Institute92020-06-202020-12-08
The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor
BC 007 - Cardiomyopathy, Dilated, Heart Failure
Phase 2CompletedBerlin Cures GmbH302019-03-292023-04-03
Simvastatin Therapy in Patients With Dilated Cardiomyopathy.
Simvastatin - Dilated Cardiomyopathy
Phase 2CompletedNational Taiwan University Hospital82019-01-172022-08-03
Bisoprolol in DMD Early Cardiomyopathy
Bisoprolol Fumarate - Duchenne Muscular Dystrophy, Cardiomyopathy, Dilated
Phase 2 / Phase 3UnknownPeking Union Medical College Hospital422019-01-162022-09-28
Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM
Bone marrow derived mononuclear cells and G-CSF - Dilated Cardiomyopathy
Phase 2Active not recruitingBarts & The London NHS Trust202018-12-242026-04-06
v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491
MYK-491, Placebo - Heart Failure With Reduced Ejection Fraction, Dilated Cardiomyopathy
Phase 1 / Phase 2CompletedBristol-Myers Squibb522018-02-062023-02-02
Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study
Left Cardiac Sympathetic Denervation (LCSD), Optimal Medical Therapy - Dilated Cardiomyopathy, Ischemic Cardiomyopathy
Phase 2SuspendedUniversity of Cape Town302016-11-242021-05-06
Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril
Enalapril Orodispersible Minitablet - Heart Failure, Dilated Cardiomyopathy
Phase 2 / Phase 3UnknownEthicare GmbH1002016-03-012016-01-13
Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy
Enalapril Orodispersible Minitablet - Heart Failure, Dilated Cardiomyopathy
Phase 2 / Phase 3UnknownEthicare GmbH502016-01-012016-01-12
Honey in Idiopathic Dilated Cardiomyopathy
honey - Idiopathic Dilated Cardiomyopathy
Phase 2 / Phase 3Completedmamdouh abdulmaksoud abdulrhman502015-11-012016-12-12
A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
ARRY-371797, p38 inhibitor, oral - LMNA-Related Dilated Cardiomyopathy
Phase 2CompletedPfizer82015-02-022022-03-31

Showing 20 of 46. Sign in to see all of them.

Narrower conditions

Heart Failure (24)  ·  Cardiomyopathies (7)  ·  Coronary Disease (2)  ·  Laminopathies (2)  ·  Campomelic Dysplasia (1)  ·  Cardiovascular Diseases (1)  ·  Distal Myopathies (1)  ·  Heart Defects, Congenital (1)  ·  Heart Diseases (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Muscular Dystrophy, Duchenne (1)  ·  Myocardial Ischemia (1)  ·  familial dilated cardiomyopathy (1)

Broader conditions

Cardiomegaly (46)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (46)  ·  Genetic Diseases, Inborn (46)  ·  Cardiovascular Diseases (45)  ·  Heart Diseases (45)  ·  Laminopathies (44)  ·  Cardiomyopathies (39)  ·  Vascular Diseases (3)  ·  Congenital Abnormalities (2)  ·  Muscular Diseases (2)  ·  Muscular Disorders, Atrophic (2)  ·  Muscular Dystrophies (2)  ·  Musculoskeletal Diseases (2)  ·  Myocardial Ischemia (2)  ·  Nervous System Diseases (2)

Interventions

ARRY-371797 (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Standard of Care (2)  ·  Allopurinol (1)  ·  Bisoprolol (1)  ·  Cardiac Resynchronization Therapy (1)  ·  Dobutamine (1)  ·  Drug Therapy (1)  ·  Honey (1)  ·  Ivabradine (1)  ·  Lenograstim (1)  ·  Perhexiline (1)  ·  Positron-Emission Tomography (1)  ·  Ranolazine (1)  ·  Simvastatin (1)

Sponsors

University Medical Centre Ljubljana (4)  ·  Barts & The London NHS Trust (2)  ·  Bristol-Myers Squibb (2)  ·  Ethicare GmbH (2)  ·  Instituto de Cardiologia do Rio Grande do Sul (2)  ·  LoneStar Heart, Inc. (2)  ·  National Taiwan University Hospital (2)  ·  Pfizer (2)  ·  Vericel Corporation (2)  ·  Affinia Therapeutics (1)  ·  Ain Shams University (1)  ·  Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud (1)  ·  Bambino Gesù Hospital and Research Institute (1)  ·  Berlin Cures GmbH (1)  ·  Celladon Corporation (1)

Countries

United States (14)  ·  United Kingdom (8)  ·  Germany (5)  ·  Netherlands (4)  ·  Slovenia (4)  ·  Spain (4)  ·  China (3)  ·  Serbia (3)  ·  Austria (2)  ·  Brazil (2)  ·  France (2)  ·  Hungary (2)  ·  Italy (2)  ·  Poland (2)  ·  Taiwan (2)

Top investigators

Ida Jovanovic, Prof,MD,PhD (2)  ·  Michael Burch, Prof,MD,PhD (2)  ·  A. G. Kfoury, MD (1)  ·  Amit Patel, MD (1)  ·  Andreas M Zeiher (1)  ·  Andrew Kao, MD (1)  ·  Anthony Mathur (1)  ·  Anthony Mathur, MD FRCP FESC (1)  ·  Antonio Torrers, MD, PhD (1)  ·  Barry Greenberg, MD (1)  ·  Barry London, MD (1)  ·  Bojan Vrtovec, MD, PhD (1)  ·  Brian Halliday, MBChB PhD (1)

Results publications

PMID 25142002, PMID 36718638, PMID 38979608, PMID 18553028, PMID 19327618, PMID 21440864, PMID 21645332, PMID 21709064, PMID 22651868, PMID 22936827, PMID 23065358, PMID 23362308, PMID 24030420, PMID 24065463, PMID 25097199, PMID 25354998, PMID 25459687, PMID 25650370, PMID 26082085, PMID 26555602, PMID 28636901, PMID 28974553, PMID 29380563, PMID 29654125, PMID 29880546, PMID 30005555, PMID 31438858, PMID 31616309, PMID 34048282, PMID 36114020, PMID 36515663, PMID 37010012, PMID 37190883, PMID 40145630, PMID 41217321

NIH funding

2015 (2), 2019 (2), 2004 (1), 2009 (1), 2018 (1), 2025 (1), K23HL071562 (1), R01HL080152 (1), R01HL110737 (1)